Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/15260
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.otherUniversidad San Pablo-CEU. Facultad de Medicina. Departamento de Ciencias Médicas Básicas-
dc.contributor.otherGrupo: Enfermedades inmunológicas inflamatorias (ALLERGY)-
dc.creatorJavierre, Biola-
dc.creatorRodríguez-Ubreva, Javier-
dc.creatorAl-Shahrour, Fátima-
dc.creatorCorominas, Marina-
dc.creatorGraña, Osvaldo-
dc.creatorCiudad, Laura-
dc.creatorAgirre, Xabier-
dc.creatorPisano, David G.-
dc.creatorValencia, Alfonso-
dc.creatorRomán Gómez, José-
dc.creatorCalasanz, María José-
dc.creatorPrósper Cardoso, Felipe-
dc.creatorEsteller, Manel-
dc.creatorGonzález Sarmiento, Rogelio-
dc.creatorBallestar, Esteban-
dc.date.accessioned2024-01-31T19:25:33Z-
dc.date.available2024-01-31T19:25:33Z-
dc.date.issued2011-07-07-
dc.identifier.citationJavierre BM, Rodriguez-Ubreva J, Al-Shahrour F, Corominas M, Graña O, Ciudad L, Agirre X, Pisano DG, Valencia A, Roman-Gomez J, Calasanz MJ, Prosper F, Esteller M, Gonzalez-Sarmiento R, Ballestar E. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells. Mol Cancer Res. 2011 Aug;9(8):1139-51. doi: 10.1158/1541-7786.MCR-10-0515. Epub 2011 Jul 7. Erratum in: Mol Cancer Res. 2011 Oct;9(10):1429-32. PMID: 21737484-
dc.identifier.issn1557-3125-
dc.identifier.urihttp://hdl.handle.net/10637/15260-
dc.description.abstractTranscription factors are common targets of epigenetic inactivation in human cancer. Promoter hypermethylation and subsequent silencing of transcription factors can lead to further deregulation of their targets. In this study, we explored the potential epigenetic deregulation in cancer of Ikaros family genes, which code for essential transcription factors in cell differentiation and exhibit genetic defects in hematologic neoplasias. Unexpectedly, our analysis revealed that Ikaros undergoes very specific promoter hypermethylation in colorectal cancer, including in all the cell lines studied and around 64% of primary colorectal adenocarcinomas, with increasing proportions in advanced Duke's stages. Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing (LRES) region. Reintroduction of Ikaros in colorectal cancer cells, ChIP-chip analysis, and validation in primary samples led us to identify a number of direct targets that are possibly related with colorectal cancer progression. Our results not only provide the first evidence that LRES can have functional specific effects in cancer but also identify several deregulated Ikaros targets that may contribute to progression in colorectal adenocarcinomaen_EN
dc.formatapplication/pdf-
dc.language.isoen-
dc.publisherAmerican Association for Cancer Research-
dc.relation.ispartofMolecular Cancer Research-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.es-
dc.subjectAdenocarcinomaen_EN
dc.subjectColorectal Neoplasmsen_EN
dc.subjectDNA Methylationen_EN
dc.subjectHCT116 Cellsen_EN
dc.subjectIkaros Transcription Factoren_EN
dc.subjectNeoplasm Stagingen_EN
dc.titleLong-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cellsen_EN
dc.typeArtículoes_ES
dc.identifier.doi10.1158/1541-7786.MCR-10-0515-
dc.relation.projectIDPI081346 grant from the Spanish Ministry of Science and Innovation (MICINN-ISCIII)-
dc.relation.projectID2009SGR184 AGAUR grant (Catalan Government)-
dc.centroUniversidad San Pablo-CEU-
Aparece en las colecciones: Medicina




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.